Prevention
of Lyme Disease Through Active Immunization:
Recommendations
of the Advisory Committee on Immunization Practices (ACIP)
Future Considerations
Recommendations for
Surveillance, Research, Education, and Program Evaluation Activities
- Determination
of safety, immunogenicity, and efficacy in children.
- Research
to determine optimal dosage schedules and timing of administration.
- Research
to determine the need for and spacing of booster doses
- Determination
of safety and efficacy in persons > 70 years of age.
- Research
to develop serodiagnostic tests that discriminate between infection
and vaccine- induced antibody production.
- Development
of a program of Lyme disease vaccine education for care-providers
and prospective vaccine clients.
- Development
of an information sheet to be distributed to prospective vaccine
recipients or to persons at the time of vaccine administration.
- Establishment
of post-licensure epidemiologic studies of safety, efficacy,
prevention-effectiveness, cost-effectiveness and patterns of
use.
- Develop a
program to monitor vaccine use at the local and national level
and to measure its public health and economic impact.
- Develop population-based
studies to assess the impact of vaccine use on incidence of Lyme
disease in communities.
- Continue
to develop maps of geographical distribution of Lyme disease
with improved accuracy and predictive power.
Back
to Contents
Back:
Recommendations for Use of Lyme Disease Vaccine
Next:
References
